• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 432624 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414680983 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414680983 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Momenta Pharmaceuticals Shares Sinking Lower, Down 1.4%

Published on Wed, 01/30/2013 - 13:24
By Adrienne Chilton

Momenta Pharmaceuticals (NASDAQ:MNTA) is one of today's biggest movers, down 1.4% to $12.87. The Dow Jones Industrial Average is now trading fractionally higher to 13,956 and the S&P is trading fractionally lower to 1,507.

Over the past year, Momenta Pharmaceuticals has traded in a range of $10.05 to $21.00 and is now at $12.87, 28% above that low. The 200-day and 50-day moving averages have moved 0.24% lower and 0.90% higher over the past week, respectively.

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Momenta Pharmaceuticals (NASDAQ:MNTA) has potential upside of 10.7% based on a current price of $12.87 and analysts' consensus price target of $14.25. The stock should hit resistance at its 200-day moving average (MA) of $13.57, as well as support at its 50-day MA of $11.59.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Investors look to Lighten Up on Shares o...

Ceragon Networks (NASDAQ:CRNT) is one of today's worst performing low-priced stocks, do ...

Rockwell Automation (ROK) Approaches New...

Shares of Rockwell Automation (NYSE:ROK) opened today below their pivot of $109.57 and ...

Integrys Energy (TEG) Crosses Pivot Poin...

Shares of Integrys Energy (NYSE:TEG) opened today above their pivot of $70.34 and have ...

Next Support Level for Lorillard (LO) is...

Shares of Lorillard (NYSE:LO) have bearishly opened below the pivot of $61.14 today and ...

Dr Pepper Snapple (DPS) Approaches New U...

Shares of Dr Pepper Snapple (NYSE:DPS) opened today above their pivot of $67.72 and hav ...

VeriSign (VRSN) Breaks Through Support a...

Shares of VeriSign (NASDAQ:VRSN) opened today below their pivot of $58.78 and have alre ...

DTE Energy (DTE) Crosses Pivot Point Res...

DTE Energy (NYSE:DTE) has opened bullishly above the pivot of $80.15 today and has reac ...

Sempra Energy (SRE) Crosses Pivot Point ...

Sempra Energy (NYSE:SRE) has opened bullishly above the pivot of $108.55 today and has ...